Both in Pharmaceuticals
Viridian Therapeutics vs Organon &
Over the past year VRDN returned +28.8% and OGN returned +112.1%; their daily moves had a correlation of 0.06.
VRDN +28.8% OGN +112.1%Growth of $1, one year, split-adjusted
| Metric | VRDN | OGN |
|---|---|---|
| Price | $29.06 | $13.83 |
| Market cap | $3.29B | $3.63B |
| Today | +15.53% | −0.14% |
| 1 month | +59.5% | +0.7% |
| 6 months | +65.7% | +3.1% |
| Year to date | −6.6% | +92.9% |
| 1 year | +25.5% | +106.1% |
| Revenue growth (YoY) | +278.7% | −1.7% |
| Gross margin | 100.0% | 55.2% |
| Net margin | −39726.8% | 10.4% |
| P/E (TTM) | — | 17.1× |
| Price / sales | 46.3× | 0.6× |
| Net cash | $625.7M | -$7.10B |
| Dividend yield | — | 0.58% |
| Volatility (60d) | 55.5% | 2.9% |
| Short % of float | 18.5% | 7.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).